Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension [PDF]
Cephalalgia, 2023 The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this ...
S. Mollan +15 more
semanticscholar +3 more sources
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial [PDF]
Brain : a journal of neurology, 2023 Therapeutics to reduce intracranial pressure are an unmet need. Preclinical data have demonstrated a novel strategy to lower intracranial pressure using glucagon-like peptide-1 (GLP-1) receptor signalling.
J. Mitchell +11 more
semanticscholar +3 more sources
Optic Nerve Ultrasound Evaluation in Idiopathic Intracranial Hypertension
Frontiers in Medicine, 2022 Idiopathic intracranial hypertension (IIH) is a disease with a heterogeneity of possible causes, which needs to be quickly diagnosed. Ocular ultrasonography could be considered a useful tool to diagnose this condition in a fast and non-invasive way.
Maddalena De Bernardo +5 more
doaj +2 more sources
Rapid Recovery of Visual Acuity after Lumboperitoneal Shunt Operation in Malignant Idiopathic Intracranial Hypertension [PDF]
Case Reports in Ophthalmological Medicine, 2011 Background. Idiopathic intracranial hypertension can cause rapid deterioration of visual acuity in some severe cases, and these cases are usually thought to have “malignant” form of this disease. Case.
Levent Sinan Bir +4 more
doaj +4 more sources
Addison's disease presenting with idiopathic intracranial hypertension in 24-year-old woman: a case report [PDF]
Journal of Medical Case Reports, 2010 Introduction Idiopathic intracranial hypertension can rarely be associated with an underlying endocrine disorder such as Cushing's syndrome, hyperthyroidism, or with administration of thyroxine or growth hormone.
Moore Peter +3 more
doaj +5 more sources
Is the adjustable lumbo-peritoneal shunt a valid option for managing symptomatic idiopathic intracranial hypertension? A case report of a multidisciplinary management [PDF]
Interdisciplinary Neurosurgery, 2019 Background: Idiopathic intracranial hypertension is a rare disorder, characterized by raised intracranial pressure with no recognizable cause. Headache, decreased visual acuity and papilledema are the main clinical manifestations.
Umberto A. Arcidiacono, M.D. +3 more
doaj +3 more sources
Idiopathic intracranial hypertension as a presenting sign of adrenal insufficiency [PDF]
SAGE Open Medical Case Reports, 2018 Idiopathic intracranial hypertension is a diagnosis of exclusion defined by elevated intracranial pressure without mass lesions or hydrocephalus.
Sandra Shenouda +3 more
doaj +3 more sources
Cluster-like headache and idiopathic intracranial hypertension: a case report [PDF]
, 2008 Cluster headache (CH) is a well-defined primary headache syndrome, but cases of symptomatic headache with clinical features of CH have been previously reported.
Lucia Testa +4 more
openalex +3 more sources
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria
Cephalalgia, 2023 Background Based on expert opinion, abducens nerve palsy and a neuroimaging criterion (≥3 neuroimaging signs suggestive of elevated intracranial pressure) were added to the diagnostic criteria for idiopathic intracranial hypertension.
J. J. Korsbæk +5 more
semanticscholar +1 more source
The Journal of Headache and Pain, 2023 Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option.
Nik Krajnc +9 more
semanticscholar +1 more source